Skip to main content

Table 1 DAA treatments schemes

From: Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

Drugs

Intended duration

Total

12 weeks

24 weeks

Other

SIM + SOF

362

–

–

362

SIM + SOF + RBV

298

2

–

300

DAC + SOF

403

262

–

665

DAC + SOF + RBV

75

319

–

394

LED + SOF

573

711

24a-

1308

LED + SOF + RBV

425

216

–

641

3D

318

–

–

318

3D + RBV

288

66

–

354

2D + RBV

58

49

–

107

SOF + RBV

175

500

15b

690

SIM + PEG + RBV

–

58

4c

62

SOF + PEG + RBV

77

1

–

78

Total

3052

2184

43

5279

  1. Number of treatments according to DAAs combination and intended duration of the therapy. a8 weeks (N = 24); b48 weeks (N = 12) and 16 weeks (N = 3); c16 weeks (N = 1) and 48 weeks (N = 3)
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us